Inventor · disambiguated record
Mark Edward Eccleston
Also filed as: ECCLESTON MARK · ECCLESTON MARK E · ECCLESTON MARK EDWARD
7 granted patents·20 pending applications·25 citations·filing 2003–2023
81Inventor score
Files withBELGIAN VOLITION SPRL8BELGIAN VOLITION SRL BE/BE5BELGIAN VOLITION SRL4SINGAPORE VOLITION PTE LTD3VALIRX PLC2
Top patents by PatentIndex Score
27 records- 0188US10746746B2Method for the enrichment of cell free nucleosomesBELGIAN VOLITION SPRL·Filed 2016·Granted Aug 18, 2020·5 cites·20 claims
- 0288US9187780B2Method for detecting nucleosome adductsSINGAPORE VOLITION PTE LTD·Filed 2012·Granted Nov 17, 2015·11 cites·21 claims
- 0387US9709569B2Method for detecting nucleosome adductsSINGAPORE VOLITION PTE LTD·Filed 2015·Granted Jul 18, 2017·5 cites·14 claims
- 0472US10768182B2Method for detecting nucleosomes containing histone modifications and variantsBELGIAN VOLITION SPRL·Filed 2016·Granted Sep 8, 2020·1 cites·8 claims
- 0568US2022334128A1Method for the enrichment of circulating tumor dnaBELGIAN VOLITION SPRL·Filed 2022·Application pending·0 cites
- 0665US2023051905A1Triaging method using cell free nucleosome levelsBELGIAN VOLITION SRL BE/BE·Filed 2022·Application pending·0 cites
- 0764US10023612B2Method of treating endometriosisVALIRX PLC·Filed 2012·Granted Jul 17, 2018·3 cites·1 claims
- 0861US2020340997A1Method for the enrichment of cell free nucleosomesBELGIAN VOLITION SPRL·Filed 2020·Application pending·0 cites
- 0960US11193939B2Method for detecting nucleosome adductsBELGIAN VOLITION SPRL·Filed 2017·Granted Dec 7, 2021·0 cites·14 claims
- 1057US2023204599A1Triaging method using cell free nucleosome levelsBELGIAN VOLITION SRL BE/BE·Filed 2021·Application pending·0 cites
- 1156US2025170241A1Chimeric antigen receptor t-cell treatments targeted to chromatin fragments and extracellular trapsBELGIAN VOLITION SRL·Filed 2023·Application pending·0 cites
- 1253US9869682B2Method for detecting the presence of a gynaecological growthSINGAPORE VOLITION PTE LTD·Filed 2015·Granted Jan 16, 2018·0 cites·6 claims
- 1352US2024318226A1Circulating transcription factor analysisBELGIAN VOLITION SRL BE/BE·Filed 2021·Application pending·0 cites
- 1452US2023226138A1Compositions and methods for treating infections and netopathyBLACK CAT BIO LTD·Filed 2021·Application pending·0 cites
- 1552US2024318255A1Transcription factor binding site analysis of nucleosome depleted circulating cell free chromatin fragmentsBELGIAN VOLITION SRL BE/BE·Filed 2021·Application pending·0 cites
- 1651US2024019432A1Diagnostic method for multiple sclerosisBELGIAN VOLITION SRL BE/BE·Filed 2021·Application pending·0 cites
- 1751US2025012783A1Homogeneous immunoassay methodBELGIAN VOLITION SRL·Filed 2022·Application pending·0 cites
- 1849US2018024141A1Method for the enrichment of circulating tumor dnaBELGIAN VOLITION SPRL·Filed 2015·Application pending·0 cites
- 1948US2013252245A1Method for detecting the presence of a gynaecological growthMICALLEF JACOB VINCENT·Filed 2011·Application pending·0 cites
- 2047US2006172418A1Hypercoiling polymers and their use in cellular deliverySLATER NIGEL K·Filed 2003·Application pending·0 cites
- 2146US2022221470A1Method for the detection of cancerBELGIAN VOLITION SPRL·Filed 2020·Application pending·0 cites
- 2246US2022291221A1Method for the detection of prostate cancerBELGIAN VOLITION SPRL·Filed 2020·Application pending·0 cites
- 2345US2024369571A1Standardisation of nucleosome assays using biologically derived calibrantsBELGIAN VOLITION SRL·Filed 2022·Application pending·0 cites
- 2443US2017003296A1Method for detecting histone modifications in nucleosomesECCLESTON MARK EDWARD·Filed 2014·Application pending·0 cites
- 2542US2023003735A1Use of cell free nucleosomes as biomarkersBELGIAN VOLITION SRL·Filed 2020·Application pending·0 cites
- 2636US2018273585A1Medical UseVALIRX PLC·Filed 2018·Application pending·0 cites
- 2733US2018087089A1Method for Analysing Nuclease Hypersensitive SitesHYPERGENOMICS PTE LTD·Filed 2016·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Mark Edward Eccleston files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →